Alain Diaz

Abri President

Mr. Diaz founded ABRI in 2008 in Miami, FL. Under his guidance, ABRI grew from a single dedicated biomedical center in, to a network of research sites and plasmapheresis centers in the United States, South America, and Africa. ABRI’s therapeutic capabilities in areas such as infectious disease, neurology, nephrology, dermatology, and women's health to facilitate more complex trials for novel drugs. Alain oversees operations as the company more than doubled its clinical and operational staff companywide. To accommodate high-volume trials and spikes in COVID-19 interest, Alain directed ABRI's implementation of increased staffing, increased clinic hours, and other strategic projects to scale operations.